Integrilin

Product NDC: 0085-1136
11-digit product format: 000851136
Labeler code: 0085
Product ID: 0085-1136_18b14fcd-6c25-4112-876f-1dd811c95ed4
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Eptifibatide
Dosage form: INJECTION, SOLUTION
Route: INTRAVENOUS
Labeler: Merck Sharp & Dohme Corp.
Application: NDA020718
Marketing category: NDA
Marketing start: 1998-05-18
Marketing end: 0000-00-00
Substance: EPTIFIBATIDE
Active strength: 1 mg/mL
Pharmacologic classes: Decreased Platelet Aggregation [PE],Platelet Aggregation Inhibitor [EPC]
NDC exclude flag: No
Listing certified through: 2022-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 6 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	0085-1136		D	Discontinued by firm	2026-08-17
excluded product	product	0085-1136		D	Discontinued by firm	2026-08-17
excluded product	product	0085-1136		D	Discontinued by firm	2026-08-17
excluded package	package	0085-1136	0085-1136-01	D	Discontinued by firm	2026-08-17
excluded package	package	0085-1136	0085-1136-03	D	Discontinued by firm	2026-08-17
excluded package	package	0085-1136	0085-1136-02	D	Discontinued by firm	2026-08-17

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 2 · 72 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	0085-1136-02	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	0085-1136-03	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	0085-1136-01	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	0085-1136-02	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	0085-1136-03	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	0085-1136-01	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	0085-1136-02	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	0085-1136-03	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	0085-1136-01	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	0085-1136-02	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	0085-1136-03	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	0085-1136-01	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	0085-1136-02	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	0085-1136-03	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	0085-1136-01	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	0085-1136-02	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	0085-1136-03	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	0085-1136-01	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	0085-1136-02	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	0085-1136-03	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	0085-1136-01	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	0085-1136-02	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	0085-1136-03	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	0085-1136-01	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	0085-1136-02	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	0085-1136-03	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	0085-1136-01	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	0085-1136-02	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	0085-1136-03	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	0085-1136-01	`ad56d346431e…`	`cc804d4bbf1e…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N020718-001	INTEGRILIN	EPTIFIBATIDE	2MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	INJECTABLE / INJECTION		RLD	1998-05-18
N020718-002	INTEGRILIN	EPTIFIBATIDE	75MG/100ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	INJECTABLE / INJECTION		RLD	1998-05-18

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 84 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	N020718-001	INTEGRILIN	2MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	INJECTABLE / INJECTION		RLD	1998-05-18	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N020718-002	INTEGRILIN	75MG/100ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	INJECTABLE / INJECTION		RLD	1998-05-18	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N020718-001	INTEGRILIN	2MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	INJECTABLE / INJECTION		RLD	1998-05-18	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020718-002	INTEGRILIN	75MG/100ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	INJECTABLE / INJECTION		RLD	1998-05-18	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020718-001	INTEGRILIN	2MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	INJECTABLE / INJECTION		RLD	1998-05-18	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020718-002	INTEGRILIN	75MG/100ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	INJECTABLE / INJECTION		RLD	1998-05-18	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N020718-001	INTEGRILIN	2MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	INJECTABLE / INJECTION		RLD	1998-05-18	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N020718-002	INTEGRILIN	75MG/100ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	INJECTABLE / INJECTION		RLD	1998-05-18	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N020718-001	INTEGRILIN	2MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	INJECTABLE / INJECTION		RLD	1998-05-18	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N020718-002	INTEGRILIN	75MG/100ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	INJECTABLE / INJECTION		RLD	1998-05-18	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N020718-001	INTEGRILIN	2MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	INJECTABLE / INJECTION		RLD	1998-05-18	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N020718-002	INTEGRILIN	75MG/100ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	INJECTABLE / INJECTION		RLD	1998-05-18	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N020718-001	INTEGRILIN	2MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	INJECTABLE / INJECTION		RLD	1998-05-18	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N020718-002	INTEGRILIN	75MG/100ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	INJECTABLE / INJECTION		RLD	1998-05-18	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N020718-001	INTEGRILIN	2MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	INJECTABLE / INJECTION		RLD	1998-05-18	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N020718-002	INTEGRILIN	75MG/100ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	INJECTABLE / INJECTION		RLD	1998-05-18	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N020718-001	INTEGRILIN	2MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	INJECTABLE / INJECTION		RLD	1998-05-18	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N020718-002	INTEGRILIN	75MG/100ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	INJECTABLE / INJECTION		RLD	1998-05-18	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N020718-001	INTEGRILIN	2MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	INJECTABLE / INJECTION		RLD	1998-05-18	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N020718-002	INTEGRILIN	75MG/100ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	INJECTABLE / INJECTION		RLD	1998-05-18	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N020718-001	INTEGRILIN	2MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	INJECTABLE / INJECTION		RLD	1998-05-18	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N020718-002	INTEGRILIN	75MG/100ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	INJECTABLE / INJECTION		RLD	1998-05-18	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N020718-001	INTEGRILIN	2MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	INJECTABLE / INJECTION		RLD	1998-05-18	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N020718-002	INTEGRILIN	75MG/100ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	INJECTABLE / INJECTION		RLD	1998-05-18	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N020718-001	INTEGRILIN	2MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	INJECTABLE / INJECTION		RLD	1998-05-18	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N020718-002	INTEGRILIN	75MG/100ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	INJECTABLE / INJECTION		RLD	1998-05-18	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N020718-001	INTEGRILIN	2MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	INJECTABLE / INJECTION		RLD	1998-05-18	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N020718-002	INTEGRILIN	75MG/100ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	INJECTABLE / INJECTION		RLD	1998-05-18	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N020718-001	INTEGRILIN	2MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	INJECTABLE / INJECTION		RLD	1998-05-18	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	N020718-002	INTEGRILIN	75MG/100ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	INJECTABLE / INJECTION		RLD	1998-05-18	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N020718-001	INTEGRILIN	2MG/ML	INJECTABLE / INJECTION		RLD	1998-05-18	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N020718-002	INTEGRILIN	75MG/100ML	INJECTABLE / INJECTION		RLD	1998-05-18	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N020718-001	INTEGRILIN	2MG/ML	INJECTABLE / INJECTION		RLD	1998-05-18	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	N020718-002	INTEGRILIN	75MG/100ML	INJECTABLE / INJECTION		RLD	1998-05-18	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N020718-001	INTEGRILIN	2MG/ML	INJECTABLE / INJECTION		RLD	1998-05-18	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	N020718-002	INTEGRILIN	75MG/100ML	INJECTABLE / INJECTION		RLD	1998-05-18	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N020718-001	INTEGRILIN	2MG/ML	INJECTABLE / INJECTION	AP	RLD, RS	1998-05-18	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N020718-002	INTEGRILIN	75MG/100ML	INJECTABLE / INJECTION	AP	RLD, RS	1998-05-18	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N020718-001	INTEGRILIN	2MG/ML	INJECTABLE / INJECTION		RLD	1998-05-18	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	N020718-002	INTEGRILIN	75MG/100ML	INJECTABLE / INJECTION		RLD	1998-05-18	`bb7c543d1eb4…`

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2019-12-13 00:20 UTC	2019-12	N020718-001	AP	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N020718-002	AP	1	`74a2ff9319b5…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N020718-001	AP	1	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N020718-002	AP	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N020718-001	AP	1	`5aa47cf7b7d7…`
2021-03-12 10:30 UTC	2021-03	N020718-002	AP	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N020718-001	AP	1	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	N020718-002	AP	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N020718-001	AP	1	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	N020718-002	AP	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N020718-001	AP	1	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N020718-002	AP	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N020718-001	AP	1	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N020718-002	AP	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N020718-001	AP	1	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	N020718-002	AP	1	`ea99ee380514…`

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Indexing SPL table
NDC	Effective	Indexing SPL	Related label
0085-1136-01	2020-07-30	ab0e2407-2d33-f274-e053-dbdaa90a6471	These highlights do not include all the information needed to use INTEGRILIN safely and effectively. See full prescribing information for INTEGRILIN. INTEGRILIN ® (eptifibatide) injection, for intravenous use Initial U.S. Approval: 1998
0085-1136-02	2020-07-30	ab0e2407-35d5-f274-e053-dbdaa90a6471	These highlights do not include all the information needed to use INTEGRILIN safely and effectively. See full prescribing information for INTEGRILIN. INTEGRILIN ® (eptifibatide) injection, for intravenous use Initial U.S. Approval: 1998
0085-1136-03	2020-07-30	ab0e2407-3397-f274-e053-dbdaa90a6471	These highlights do not include all the information needed to use INTEGRILIN safely and effectively. See full prescribing information for INTEGRILIN. INTEGRILIN ® (eptifibatide) injection, for intravenous use Initial U.S. Approval: 1998
0085-1136-01	2020-07-22	ab0e2407-2d33-f274-e053-dbdaa90a6471	These highlights do not include all the information needed to use INTEGRILIN safely and effectively. See full prescribing information for INTEGRILIN. INTEGRILIN ® (eptifibatide) injection, for intravenous use Initial U.S. Approval: 1998
0085-1136-02	2020-07-22	ab0e2407-35d5-f274-e053-dbdaa90a6471	These highlights do not include all the information needed to use INTEGRILIN safely and effectively. See full prescribing information for INTEGRILIN. INTEGRILIN ® (eptifibatide) injection, for intravenous use Initial U.S. Approval: 1998
0085-1136-03	2020-07-22	ab0e2407-3397-f274-e053-dbdaa90a6471	These highlights do not include all the information needed to use INTEGRILIN safely and effectively. See full prescribing information for INTEGRILIN. INTEGRILIN ® (eptifibatide) injection, for intravenous use Initial U.S. Approval: 1998

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0085-1136-01	ML - Milliliter	0085-1136	923fbb58-a6ff-4628-9354-0fe6c0f1eb60	1	2012-07-24
0085-1136-02	ML - Milliliter	0085-1136	e0bc8f86-9461-4199-8627-509a015074e7	1	2014-09-03
0085-1136-03	ML - Milliliter	0085-1136	492fc689-4aae-4c99-b8d7-beacb08a2583	1	2015-06-09

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
Eptifibatide	ACTIVE INGREDIENT	NA8320J834	INTEGRILIN (EPTIFIBATIDE) INJECTION, SOLUTION [MERCK SHARP & DOHME CORP.]	13
Eptifibatide	ACTIVE MOIETY	NA8320J834	INTEGRILIN (EPTIFIBATIDE) INJECTION, SOLUTION [MERCK SHARP & DOHME CORP.]	13
Citric Acid Monohydrate	INACTIVE INGREDIENT	2968PHW8QP	INTEGRILIN (EPTIFIBATIDE) INJECTION, SOLUTION [MERCK SHARP & DOHME CORP.]	13
Sodium Hydroxide	INACTIVE INGREDIENT	55X04QC32I	INTEGRILIN (EPTIFIBATIDE) INJECTION, SOLUTION [MERCK SHARP & DOHME CORP.]	13
Eptifibatide	ACTIVE INGREDIENT	NA8320J834	INTEGRILIN (EPTIFIBATIDE) INJECTION, SOLUTION [MERCK SHARP & DOHME CORP.]	2
Eptifibatide	ACTIVE MOIETY	NA8320J834	INTEGRILIN (EPTIFIBATIDE) INJECTION, SOLUTION [MERCK SHARP & DOHME CORP.]	2
Citric Acid Monohydrate	INACTIVE INGREDIENT	2968PHW8QP	INTEGRILIN (EPTIFIBATIDE) INJECTION, SOLUTION [MERCK SHARP & DOHME CORP.]	2
Sodium Hydroxide	INACTIVE INGREDIENT	55X04QC32I	INTEGRILIN (EPTIFIBATIDE) INJECTION, SOLUTION [MERCK SHARP & DOHME CORP.]	2
Eptifibatide	ACTIVE INGREDIENT	NA8320J834	INTEGRILIN (EPTIFIBATIDE) INJECTION, SOLUTION [MERCK SHARP & DOHME CORP.]	1
Eptifibatide	ACTIVE MOIETY	NA8320J834	INTEGRILIN (EPTIFIBATIDE) INJECTION, SOLUTION [MERCK SHARP & DOHME CORP.]	1
Citric Acid Monohydrate	INACTIVE INGREDIENT	2968PHW8QP	INTEGRILIN (EPTIFIBATIDE) INJECTION, SOLUTION [MERCK SHARP & DOHME CORP.]	1
Sodium Hydroxide	INACTIVE INGREDIENT	55X04QC32I	INTEGRILIN (EPTIFIBATIDE) INJECTION, SOLUTION [MERCK SHARP & DOHME CORP.]	1

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
NA8320J834	EPTIFIBATIDE	188627-80-7	EPTIFIBATIDE

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
0085-1136-01	00085113601	1 VIAL, SINGLE-USE in 1 CARTON (0085-1136-01) > 100 mL in 1 VIAL, SINGLE-USE	1998-05-18	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Integrilin	Merck Sharp & Dohme Corp.	2021-03-05	HUMAN PRESCRIPTION DRUG LABEL	18
Integrilin	Merck Sharp & Dohme Corp.	2019-11-01	HUMAN PRESCRIPTION DRUG LABEL	4
Integrilin	Merck Sharp & Dohme Corp.	2019-11-01	HUMAN PRESCRIPTION DRUG LABEL	3